The Challenge

A global biopharmaceutical company wanted to create a policy and advocacy launch strategy for a novel treatment in development for head and neck  squamous cell carcinomas (HNSCC) – a new indication for this team.

Our Solution

• Analyzed government and payer policies, funding and resourcing priorities, gaps, and proposed legislation.

• Mapped patient experience to understand unmet needs:

  • Insufficient curative treatments

  • Poor outcomes due to underdiagnosis and late diagnosis

  • Increased risk of depression and suicidality among stigmatized survivors

  • Disparities in access to care and socioeconomic status

• Chartered the advocacy landscape recommending organizations and KOLs.

• Identified shared interests and engagement opportunities aligned to strategic imperatives and launch timelines.

• Reviewed competitor activities to identify program strengths and gaps.

• Developed a strategic plan to guide policy and patient advocacy engagement activities.

• Drafted an operational plan to support smooth execution.

Benefit to Client

• Comprehensive HNSCC Policy and Advocacy Insights: Attained insights into the current and evolving HNSCC policy and advocacy landscape.

• Influential Stakeholder Comprehension: Understanding of key stakeholders influencing the HNSCC space, unmet patient needs they are working to address, and partnership opportunities to leverage.

• Strategic Engagement Blueprint: Developed a policy and advocacy engagement strategy supporting product launch needs.

• Policy Monitoring and Stakeholder Engagement: Established a well-defined plan for monitoring pertinent policies in the HNSCC arena and engaging with relevant stakeholders.